Chuang Chi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chuang Chi has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Jiexue Pan
Reproductive Medicine Center, The First Affiliated Hospital of Wenzhou Medical University, No. 96 Fuxue Road, Wenzhou, 325000, People’s Republic of China
2 shared publicationsLili Yang
Radiology Department, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, 325000, People’s Republic of China
2 shared publications- Xiaoming Lin
Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
2 shared publications - Yi Yang
Department of Clinical Skills Experiments Center, Wenzhou Medical College, Wenzhou, China
2 shared publications - Yu Liu
Department of Cardiac and Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical College, 2#, Fuxue Lane, Wenzhou, 325000, China
2 shared publications - Chao-Xi Lin
Department of Cardiac and Thoracic Surgery, the First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
1 shared publication
Latest Publications
- Open Access
- 25 October 2018
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 16 (1) , 104
Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome
The prevalecne of hyperuricemia in polycystic ovary syndrome (PCOS) is still uncertain. We aimed to investigate the prevalence of hyperuricemia in PCOS and to determine the influence of reproductive hormones on uric acid concentration. This retrospective cross-sectional study was performed at a large reproductive medicine center. Between March 2007 and October 2016, a total of 1,183 women with PCOS and 10,772 women without PCOS were included. PCOS was diagnosed according to the Rotterdam criteria. Anthropometric parameters, blood pressure, uric acid, reproductive hormones, glucose and lipids were measured in all subjects. The serum uric acid (SUA) level was higher in women with PCOS than in women without PCOS. The prevalence of hyperuricemia in women with PCOS (25.48%) was significantly higher than that in women without PCOS (8.74%). Analysis stratified for age and body mass index (BMI) showed that both the SUA level and the prevalence of hyperuricemia were higher in women with PCOS of different age and BMI groups than in women without PCOS. After adjusting for age, BMI and estimated glomerular filtration rate (eGFR), logistic regression analysis revealed that the luteinizing/follicle-stimulating hormone (LH/FSH) ratio (odds ratio (OR) = 1.20, 95% CI = 1.01–1.43) and testosterone level (OR = 1.56, 95% CI = 1.27–1.90) were positively associated with the prevalence of hyperuricemia in females with PCOS. The serum uric acid (SUA) level and the prevalence of hyperuricemia markedly increased in women with PCOS. The testosterone level was positively associated with the SUA level and the prevalence of hyperuricemia in females with PCOS.
- 25 October 2018
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 16 (1) , 104
Open AccessAssociation between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome
The prevalecne of hyperuricemia in polycystic ovary syndrome (PCOS) is still uncertain. We aimed to investigate the prevalence of hyperuricemia in PCOS and to determine the influence of reproductive hormones on uric acid concentration. This retrospective cross-sectional study was performed at a large reproductive medicine center. Between March 2007 and October 2016, a total of 1,183 women with PCOS and 10,772 women without PCOS were included. PCOS was diagnosed according to the Rotterdam criteria. Anthropometric parameters, blood pressure, uric acid, reproductive hormones, glucose and lipids were measured in all subjects. The serum uric acid (SUA) level was higher in women with PCOS than in women without PCOS. The prevalence of hyperuricemia in women with PCOS (25.48%) was significantly higher than that in women without PCOS (8.74%). Analysis stratified for age and body mass index (BMI) showed that both the SUA level and the prevalence of hyperuricemia were higher in women with PCOS of different age and BMI groups than in women without PCOS. After adjusting for age, BMI and estimated glomerular filtration rate (eGFR), logistic regression analysis revealed that the luteinizing/follicle-stimulating hormone (LH/FSH) ratio (odds ratio (OR) = 1.20, 95% CI = 1.01–1.43) and testosterone level (OR = 1.56, 95% CI = 1.27–1.90) were positively associated with the prevalence of hyperuricemia in females with PCOS. The serum uric acid (SUA) level and the prevalence of hyperuricemia markedly increased in women with PCOS. The testosterone level was positively associated with the SUA level and the prevalence of hyperuricemia in females with PCOS.
- 20 March 2018
- Published by Springer Nature in Endocrine
- Vol. 61 (2) , 204-209
Age at menarche and the risk of gestational diabetes mellitus: a systematic review and meta-analysis
Epidemiological studies had demonstrated that early age at menarche increased the risk of type 2 diabetes (T2DM), and gestational diabetes mellitus (GDM) shares many risk factors and features with T2DM. Thus, age at menarche may be a potential factor in the development of GDM. The aim of this study was to assess the association between age at menarche and the risk of gestational diabetes mellitus.
- 20 March 2018
- Published by Springer Nature in Endocrine
- Vol. 61 (2) , 204-209
Age at menarche and the risk of gestational diabetes mellitus: a systematic review and meta-analysis
Epidemiological studies had demonstrated that early age at menarche increased the risk of type 2 diabetes (T2DM), and gestational diabetes mellitus (GDM) shares many risk factors and features with T2DM. Thus, age at menarche may be a potential factor in the development of GDM. The aim of this study was to assess the association between age at menarche and the risk of gestational diabetes mellitus.
- Open Access
- 17 March 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 50
Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature
Primary pleural squamous cell carcinoma is very rare, and there is a lack of experience in the diagnosis and treatment of this condition. An asymptomatic 75-year-old man was referred to us after a right pleural nodule was found on computed tomography during a routine health examination. He underwent surgery for his pleural tumor twice over the following 2 years. Histopathological examination eventually led to a diagnosis of primary pleural squamous cell carcinoma.
- 17 March 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 50
Open AccessPrimary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature
Primary pleural squamous cell carcinoma is very rare, and there is a lack of experience in the diagnosis and treatment of this condition. An asymptomatic 75-year-old man was referred to us after a right pleural nodule was found on computed tomography during a routine health examination. He underwent surgery for his pleural tumor twice over the following 2 years. Histopathological examination eventually led to a diagnosis of primary pleural squamous cell carcinoma.
- 1 February 2013
- Published by Wolters Kluwer Health
- Vol. 35 (2) , 129-31
[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].
To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.
- 1 February 2013
- Published by Wolters Kluwer Health
- Vol. 35 (2) , 129-31
[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].
To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.
- Open Access
- 6 March 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 18
Efficacy of an absorbable polyglycolic acid patch in surgery for pneumothorax due to silicosis
Background: We conducted a retrospective study to evaluate the efficacy and safety of an absorbable polyglycolic acid (PGA) patch in surgery for refractory pneumothorax due to silicosis. Methods: A retrospective analysis was performed of 56 patients who received thoracotomy or thoracoscopic surgery for refractory pneumothorax due to silicosis between 1995 and 2010. An absorbable PGA patch was used as a reinforcement or repair material after resection of the bulla in 24 operations and it was not used in another 32 operations. Clinical outcomes were compared between the two groups (with a PGA and without a PGA). Results: We found that the duration of postoperative chest drainage (5.04 ± 1.12 days vs. 8.19 ± 1.60 days, p < 0.01) and hospital stay after the operation (8.33 ± 1.34 days vs. 11.56 ± 1.50 days, p < 0.01) were significantly shorter in patients who used an absorbable PGA patch in the operation compared with those who did not use a PGA patch. The incidence of initial air leakage (58.3% [14/24] vs. 93.8% [30/32], p < 0.05) and relapse rate of pneumothorax in 6 months (4% [1/24] vs. 25% [8/32], p < 0.05) were also significantly lower in patients who used an absorbable PGA patch in the operation compared with those who did not use a PGA patch. No related adverse effects of the absorbable PGA patch occurred after the operations. Conclusions: Use of an absorbable PGA patch as a reinforcement or repair material in surgery for refractory pneumothorax due to silicosis can reduce postoperative air leakage and improve clinical outcome.
- 6 March 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 18
Open AccessEfficacy of an absorbable polyglycolic acid patch in surgery for pneumothorax due to silicosis
Background: We conducted a retrospective study to evaluate the efficacy and safety of an absorbable polyglycolic acid (PGA) patch in surgery for refractory pneumothorax due to silicosis. Methods: A retrospective analysis was performed of 56 patients who received thoracotomy or thoracoscopic surgery for refractory pneumothorax due to silicosis between 1995 and 2010. An absorbable PGA patch was used as a reinforcement or repair material after resection of the bulla in 24 operations and it was not used in another 32 operations. Clinical outcomes were compared between the two groups (with a PGA and without a PGA). Results: We found that the duration of postoperative chest drainage (5.04 ± 1.12 days vs. 8.19 ± 1.60 days, p < 0.01) and hospital stay after the operation (8.33 ± 1.34 days vs. 11.56 ± 1.50 days, p < 0.01) were significantly shorter in patients who used an absorbable PGA patch in the operation compared with those who did not use a PGA patch. The incidence of initial air leakage (58.3% [14/24] vs. 93.8% [30/32], p < 0.05) and relapse rate of pneumothorax in 6 months (4% [1/24] vs. 25% [8/32], p < 0.05) were also significantly lower in patients who used an absorbable PGA patch in the operation compared with those who did not use a PGA patch. No related adverse effects of the absorbable PGA patch occurred after the operations. Conclusions: Use of an absorbable PGA patch as a reinforcement or repair material in surgery for refractory pneumothorax due to silicosis can reduce postoperative air leakage and improve clinical outcome.